Compounds > n-n-propylnorapomorphine
Page last updated: 2024-08-23

n-n-propylnorapomorphine and Parkinson Disease

n-n-propylnorapomorphine has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stewart, RM1
Baronti, F; Chase, TN; Conant, K; Davis, TL; Giuffra, M; Heuser, IJ; Mouradian, MM1

Other Studies

2 other study(ies) available for n-n-propylnorapomorphine and Parkinson Disease

ArticleYear
Parkinson's disease: new treatments.
    Comprehensive therapy, 1981, Volume: 7, Issue:4

    Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus

1981
Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:5

    Topics: Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Intravenous; Levodopa; Middle Aged; Parkinson Disease; Receptors, Dopamine

1991